BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 45 found
  Current Search:  bioterror: 97, terror: 190, anthrax: 122, smallpox: 76     

HTML
52%
Aethlon Medical Announces Second HIV/AIDS Treatment Site
- Aethlon Medical, Inc.

(OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India.

Aethlon previously disclosed plans to initiate the 'first-in-man' clinical study of...

Pharma Live:  Jul 1 2008 1:45PM
Matching: bioterror smallpox
Find similar documents
HTML
52%
Aethlon Medical Announces Second HIV/AIDS Treatment Site
Aethlon Medical Inc (AEMD) Stock Quote, Chart, News, Add to Watchlist Aethlon Medical, Inc.

AEMD announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India.

Aethlon previously...

Business Wire via MSN Money:  Jul 1 2008 11:35AM
Matching: bioterror smallpox
Find similar documents
HTML
52%
Aethlon Medical Announces Second HIV/AIDS Treatment Site
Company Website: http://www.aethlonmedical.com SAN DIEGO -- (Business Wire) Aethlon Medical, Inc.

(OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India.

Aethlon...

Stockwatch:  Jul 1 2008 11:23AM
Matching: bioterror smallpox
Find similar documents
HTML
50%
New type of ultraviolet diode could lead to compact anthrax detector
A new class of ultraviolet photodiode could make possible a compact, reliable and cost-effective sensor to detect anthrax and other bioterrorism agents in the air.

Research conducted at the Georgia Institute of Technology,...

MTB Europe:  Jun 29 2008 11:15PM
Matching: bioterror anthrax
Find similar documents
HTML
50%
Anthrax attacks in the U.S. 'suspect' awarded $2.8 million
A former U.S.

Army scientist has won his case against the United States Justice Department for being unfairly implicated in anthrax attacks in 2001.

Steven Hatfill accused the Justice Department of violating his privacy rights by...

News-Medical.Net:  Jun 30 2008 8:43AM
Matching: bioterror anthrax
Find similar documents
HTML
50%
DOR BioPharma Announces Collaboration With Numoda Corporation for the Execution of Confirmatory, Phase 3 Clini
-- DOR BioPharma, Inc.

(DORB) ('DOR' or the 'Company'), a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines against...

Houston Chronicle:  Jun 30 2008 12:47PM
Matching: bioterror anthrax
Find similar documents
HTML
52%
Aethlon to start 1st human study of Hemopurifier for HIV/AIDS
+0.00 +0.7% Released : Thursday, June 26, 2008 7:02 PM Aethlon to start 1st human study of Hemopurifier for HIV/AIDS Medical Device Daily Staff Writer Since 2001 Aethlon Medical (San Diego) has bannered its Hemopurifier as potentially the...
Calibre Macro World:  Jun 28 2008 5:49PM
Matching: bioterror smallpox
Find similar documents
HTML
52%
Aethlon Medical Featured in Medical Device Daily
- Aethlon Medical, Inc.

(OTCBB:AEMD) disclosed today that it has been featured in a cover story published in Medical Device Daily.

The story is accessible online at: www.aethlonmedical.com/pdfs/mdd062508.pdf About Aethlon Medical Aethlon...

DiGiTAL50:  Jun 28 2008 6:42AM
Matching: bioterror smallpox
Find similar documents
HTML
52%
Aethlon Medical Featured in Medical Device Daily
, 7:30 AM EST News source: Business Wire Aethlon Medical, Inc.

(OTCBB:AEMD) disclosed today that it has been featured in a cover story published in Medical Device Daily.

The story is accessible online at: www.aethlonmedical.com/pdfs...

Genetic Engineering News:  Jun 27 2008 11:55AM
Matching: bioterror smallpox
Find similar documents
HTML
74%
BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland
BioNeutral announced today that Steve Browand will direct the company's efforts to sell its advanced chemical technology products to the military, Homeland Security and governmental departments.

Steve Browand said, 'I have reviewed the...

Genetic Engineering News:  Jun 25 2008 8:33PM
Matching: bioterror terror anthrax
Find similar documents
HTML
52%
Aethlon CEO Discusses 'First-In-Man' HIV Study on CEOcast
Aethlon Medical, Inc.

(OTCBB:AEMD) disclosed this evening that its CEO, James A.

Joyce, is currently featured in an on-line interview with CEOcast, Inc.

During the interview, Mr.

Joyce discusses the 'first-in-man' clinical study of...

Genetic Engineering News:  Jun 26 2008 4:38AM
Matching: bioterror smallpox
Find similar documents
HTML
51%
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of...
Clinical Lab Products:  Jun 26 2008 3:04PM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of...
Biz Journals:  Jun 26 2008 1:05PM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of...
Nashville Business Journal:  Jun 26 2008 1:01PM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of...
Portland Business Journal:  Jun 26 2008 12:53PM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of...
Atlanta Business Chronicle:  Jun 26 2008 12:50PM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Response Biomedical Corporation Announces Strategic Partnership with Roche Diagnostics To Commercialize Cardio
VANCOUVER, June 26 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it has entered into an agreement granting rights to Roche Diagnostics to market its line of cardiovascular point-of...
The Business Journal Phoenix:  Jun 26 2008 12:48PM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Vical Advances RapidResponse DNA Vaccine Platform Under $6 Million Grant from NIH
/PRNewswire-FirstCall/ -- Vical Incorporated today announced that the company has successfully completed first-year milestones under a three-year, $6.0 million grant awarded in 2007, and is advancing with the development of a DNA vaccine...
Pharma Live:  Jun 26 2008 9:24AM
Matching: anthrax smallpox
Find similar documents
HTML
51%
Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH
SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- Vical Incorporated today announced that the company has successfully completed first-year milestones under a three-year, $6.0 million grant awarded in 2007, and is advancing with the development...
SmartBrief:  Jun 25 2008 11:29AM
Matching: anthrax smallpox
Find similar documents
HTML
74%
Universal Detection Technology to Submit an Operational Requirements Document on Recommendation of the Departm
Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-...
NewsBlaze:  Jun 24 2008 11:53AM
Matching: bioterror terror anthrax
Find similar documents
HTML
74%
Universal Detection Technology to Submit an Operational Requirements Document on Recommendation of the Departm
, 4:01 AM EST Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider...
Genetic Engineering News:  Jun 24 2008 11:37AM
Matching: bioterror terror anthrax
Find similar documents
HTML
52%
Aethlon Medical Announces ''First-In-Man'' HIV/AIDS Treatment Study
SAN DIEGO--(BUSINESS WIRE)--Aethlon Medical, Inc.

(OTCBB: AEMD.OB) announced today that it has entered into an agreement to initiate the first-in-man clinical study of a medical device to treat the Human Immunodeficiency Virus (HIV) which...

Yahoo! Canada:  Jun 24 2008 11:28AM
Matching: bioterror smallpox
Find similar documents
HTML
52%
Aethlon Medical Announces ''First-In-Man'' HIV/AIDS Treatment Study
Author : CA-AETHLON-MEDICAL Category : Press Release News Alerts by Email ( click here ) Press Release News | Home SAN DIEGO - (Business Wire) Aethlon Medical, Inc.

(OTCBB:AEMD) announced today that it has entered into an agreement to...

Earthtimes.org:  Jun 24 2008 11:00AM
Matching: bioterror smallpox
Find similar documents
HTML
77%
Effective health messages may yield vaccine compliance among ER workers
EUREKALERT Contact: Renee Cree 215-707-1583 In the event of a pandemic, healthy first responders will be essential to provide care for the infected Emergency room workers will be the first line of defense in the event of a disease pandemic...
Genetic Engineering News:  Jun 18 2008 4:58AM
Matching: bioterror anthrax smallpox
Find similar documents
HTML
77%
Bioterrorism: Anthrax and Biotech Companies
This is the second of two articles on bioterrorism and the companies involved in the field.

The first article was on Smallpox.

This one is on Anthrax.

Anthrax is caused by the gram-positive bacterium Bacillus...

Seeking Alpha:  Jun 17 2008 9:51AM
Matching: bioterror anthrax smallpox
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.